Lipoplus

Omega-3-acid triglycerides, the active ingredient in Lipoplus, is a intravenous lipid emulsion presented as an intravenous formulation for intravenous use. It supplies calories and essential fatty acids to patients requiring parenteral nutrition, such as those unable to receive enteral feeding.

GNH USA supplies Lipoplus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive care units worldwide. The company ensures quality compliance with EU standards and provides logistics support for global distribution.

Lipoplus is used in clinical settings to address nutritional and metabolic needs associated with parenteral nutrition.

Parenteral nutrition: provides a concentrated source of calories and essential fatty acids for patients receiving total parenteral nutrition. Essential fatty acid deficiency: corrects deficiency in patients lacking enteral intake of omega‑3 and omega‑6 fatty acids. Critical care energy support: serves as an energy source for critically ill patients who cannot tolerate enteral feeding.

Lipoplus may be associated with a range of infusion‑related adverse reactions.

Common Side Effects: - Hypertriglyceridemia: elevated blood triglyceride levels. - Fever: transient rise in body temperature during infusion. - Mild hypotension: temporary drop in blood pressure. - Fat overload syndrome: accumulation of fat in the reticuloendothelial system.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Liver dysfunction: marked elevation of hepatic enzymes. - Coagulopathy: impaired blood clotting due to lipid interference. - Pulmonary embolism: rare blockage of pulmonary vessels.

When using Lipoplus, clinicians should observe several safety measures.

Patient selection: assess baseline triglyceride levels and liver function before initiating therapy. Infusion rate: administer at recommended rate to reduce risk of fat overload. Monitoring: regularly check serum triglycerides, liver enzymes, and coagulation parameters. Allergy assessment: verify no known hypersensitivity to soy or fish oils. Compatibility: avoid mixing with incompatible intravenous solutions. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipoplus can interact with other medications and nutritional products; awareness of these interactions helps maintain patient safety.

Major Interactions (Avoid): - Heparin therapy: may exacerbate hypertriglyceridemia. - Cytotoxic chemotherapy: increased risk of lipid‑related organ toxicity. - High‑dose vitamin E supplements: potential for excessive antioxidant effect.

Moderate Interactions (Monitor Closely): - Warfarin: lipid emulsion can alter INR values, requiring monitoring. - Propofol infusion: additive lipid load may raise triglyceride levels. - Total parenteral nutrition containing other lipid sources: risk of cumulative fat overload.